The tPA-Challenge™ is the only in vitro diagnostic assay capable of predicting massive hemorrhage when samples are drawn at the scene-of-injury
Hear from investors, first responders, and patients their thoughts on this life-saving technology.
What's next for TTI?
What does the future hold for Thrombo Therapeutics Inc.?
roc curves tPA-challenge™
Conversely, the area under the
ROC curve of tPA-Challenged™ TEG fibrinolysis was as good as CRT MA for MH prediction
tPA-Challenge™ in trauma
With the addition of the
tPA-Challenge™, a standard TEG assay can read out the patient's tPA/PAI-1 balance
ROC Curves Rapid TEG
The area under the ROC curve of conventional rapid TEG for prediction of hemorrhage in trauma was good for samples collected in the ED, however useless for field samples
A fully developed assay, packaged for the end-user with proven efficacy in over 800 trauma patients, and shovel-ready for a pivotal trial and FDA approval.
Whether you're an investor, or interested in hearing more about our life-saving technology, drop us a line below!
©THROMBO THERAPEUTICS. ALL RIGHTS RESERVED 2019
DESIGNED BY CU DENVER STUDENT AGENCY.